PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Researchers in Japan devise method to produce steroid antibiotics

A group of steroid antibiotic compounds derived from fungi have shown promising antimicrobial activity. A group of researchers at the University of Tokyo, J...
Continue Reading →
News

GSK Applies in Japan for Approval of a Once-Daily, Single Inhaler Triple Therapy for COPD

First filing made for a triple therapy for chronic obstructive pulmonary disease offered in a single inhaler. Chronic obstructive pulmonary disease (COPD) affects...
Continue Reading →
News

Shionogi to Modernize Product Quality Management in the Cloud with Veeva Vault QMS

Pharmaceutical company in Japan unifies product quality management processes across global stakeholders Veeva Systems today announced that Shionogi & Co....
Continue Reading →
News

Pricing system reform and generics trend apparent at CPhI Japan 2018

  Bio and generic demand reflective of wider trends in the market – with overseas investments now prospering   Increased international generic API companie...
Continue Reading →
News

Japanese pharma – no longer ‘lost in translation’

A New Year report from CPhI forecasts 2018 will be a transformative year for Japanese pharma as the market evolves towards growth in generics, biosimilars and increa...
Continue Reading →
News

Swisslog follows global customers with two major contract wins in Japanese medical devices industry

Swisslog, a global provider of robot and data-driven intralogistics solutions, has been awarded contracts to optimize the storage and handling of medical devices fro...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026